BS ISO 13019:2018 - Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

Find Similar Items

This product falls into the following categories.

You may find similar items within these categories by selecting from the choices below:

BS ISO 13019:2018

Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

Status : Current   Published : June 2018

Format
PDF

Format
HARDCOPY






Standard NumberBS ISO 13019:2018
TitleTissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis
StatusCurrent
Publication Date11 June 2018
Cross ReferencesASTM F2027-00, ISO 14155-1, ISO 14155-2, ASTM F2212-02, ISO 12891-1, ISO/TS 10993-19, ISO 10993-1, ISO 9000, ISO 14971, ISO 13022, ISO 20391-1, ASTM F2150 - 07, ASTM F2312 - 04, ASTM F2315 - 03, ASTM F2383 - 05, ASTM F2210 - 02, ASTM F2451 - 05
International RelationshipsISO 13019:2018
Draft Superseded By17/30319534 DC
DescriptorsSpecimen preparation, Hygiene, Orthopaedic equipment, Test specimens, Surgery, Surgical equipment, Bioassay, Decontamination, Prosthetic devices, Biological analysis and testing, Records (documents), Sterilization (hygiene), Implants (surgical)
ICS11.040.40
Title in FrenchProduits médicaux issus de l'ingénierie tissulaire. Quantification des glycosaminoglycanes sulfatés (sGAG) pour lévaluation de la chondrogenèse
CommitteeBTI/1
ISBN978 0 580 89425 1
PublisherBSI
FormatA4
DeliveryYes
Pages24
File Size744 KB
Price£170.00


 Your basket
Your basket is empty

Take the smart route to manage medical device compliance


Get ISO 45001

BSI Essentials: All-in-one BSI online toolkit for BS ISO 45001


Worldwide Standards
We can source any standard from anywhere in the world


Collaborate, Innovate, Accelerate.